大规模神经网络相关的响应抑制与抗抑郁药响应相关的大型抑郁症
Haiyan Liu1, Yi Xia1, Xiaoqin Wang1
1Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, No. 264 Guangzhou Road, Nanjing, 210029, China.
BMC psychiatry
|September 27, 2025
概括
大型抑郁症 (MDD) 的反应抑制受损与抗抑郁药反应不佳有关. 在前端对象网络中大脑连接的减少预测了MDD患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 大型抑郁症 (MDD) 的特点是反应抑制受损.
- 这种损伤可能预测抗抑郁药治疗结果不佳.
- 这种联系的神经生理学基础仍然不清楚.
研究的目的:
- 调查MDD中响应抑制和大脑连接之间的关系.
- 为了确定抗抑郁药反应的神经生理学预测因素.
主要方法:
- 149名参与者 (77名健康对照组,72名MDD患者) 在进行Go/No-go任务时接受了磁脑扫描 (MEG).
- 患者被归类为响应者,如果他们在4周后显示≥50%的症状减少.
- 在β频段分析了全脑功能连接.
主要成果:
- 患有MDD的患者表现出右侧网络连接 (下额头) 的减少.
- 与响应者和对照者相比,非响应者在响应抑制期间表现出左侧主导的前侧双叶网络连接性 (上侧双叶环,轨道前叶皮层) 的下降.
- 这种连接模式具有对抗抑郁药治疗反应的预测潜力.
结论:
- 在左侧前侧状网络 (上侧状圈,轨道前皮层) 的连接性降低可能表明一种去补偿机制.
- 这种低连接性可能会导致一些MDD患者的治疗不敏感.
更多相关视频
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.5K
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
907
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
